1513 — Livzon Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$23.49bn
- HK$17.40bn
- CNY12.43bn
- 75
- 76
- 79
- 93
Annual cashflow statement for Livzon Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -4,532 | -4,618 | -6,247 | -5,658 | -5,018 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,767 | 2,161 | 1,902 | 2,773 | 3,249 |
| Capital Expenditures | -398 | -647 | -1,309 | -940 | -820 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 82 | 179 | -568 | -290 | 112 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -316 | -468 | -1,877 | -1,230 | -708 |
| Financing Cash Flow Items | -172 | 28.2 | -324 | -329 | -599 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,181 | -518 | -815 | -720 | -1,657 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 290 | 1,098 | -827 | 947 | 904 |